New patent for Janssen Biotech drug ERLEADA
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. […]
Patent Added
New patent for Janssen Biotech drug BALVERSA
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA.
New patent for Beigene drug BRUKINSA
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It
New patent for Neurocrine drug ONGENTYS
Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It
New patent for Janssen Biotech drug BALVERSA
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA.
New patent for Janssen Pharms drug PONVORY
Annual Drug Patent Expirations for PONVORY Ponvory is a drug marketed by Janssen Pharms and is included in one NDA.
New patent for Am Regent drug MULTRYS
Annual Drug Patent Expirations for MULTRYS Multrys is a drug marketed by Am Regent and is included in one NDA.
New patent for Am Regent drug TRALEMENT
Annual Drug Patent Expirations for TRALEMENT Tralement is a drug marketed by Am Regent and is included in one NDA.
New patent for Fennec Pharms drug PEDMARK
Annual Drug Patent Expirations for PEDMARK Pedmark is a drug marketed by Fennec Pharms Inc and is included in one
